A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions
Active, not recruiting · NCT05432583 · Registry updated 2025-10-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial in Healthy Volunteers and Volunteers With Recurrent Genital Herpes to Study the Safety, Tolerability, and Immune Responses After Vaccination With an Investigational Vaccine Designed to Prevent Genital Herpes Lesions | Genital Herpes Simplex Type 2 | Active, not recruiting | Phase 1 | 2025-10-20 | NCT05432583 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioNTech SE | 53 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Accellacare PMG Research Wilmington LLC | Wilmington | United States | 1 |
| Accellacare Raleigh Medical Group | Raleigh | United States | 1 |
| Alliance for Multispecialty Research, LLC | Tempe | United States | 4 |
| CTI Clinical Research Center | Cincinnati | United States | 24 |
| Great Lakes Clinical Trials - Flourish Research | Chicago | United States | 1 |
| Hospital of the University of Pennsylvania | Philadelphia | United States | 142 |